Skip to main content
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

297

datasets available to search

ShareScore release 0.9.0

Reset

Dataset results

297 results for “cognitive evaluation”

Learn how ShareScore rates datasets ↗
zenodo44/100

An Empirical Evaluation of the "Cognitive Complexity" Measure as a Predictor of Code Understandability

<p>The paper provides an evaluation of the &ldquo;Cognitive Complexity&rdquo; measure as an indicator of code understandability.<br> The evaluation is performed via an empirical study.<br> &quot;&quot;Cognitive Complexity&quot; is compared with traditional code measure, like LoC and McCabe&#39;s complexity.</p> <p>The data used in the empirical study are provided.</p>

opencc-by-4.0Nov 2022View details →
zenodo40/100

Evaluation Tools for Human-AI Interactions Involving Older Adults with Mild Cognitive Impairments

<h1>Abstract</h1> <p>As artificial intelligence (AI) systems have already proven useful in human lives generally, there is an opportunity for specialized human-AI interaction (HAI) systems to support and provide care for older adults with mild cognitive impairment (MCI). However, the integration of this technology in this population must be thoughtfully designed to accommodate specific needs and limitations. This includes careful measurement of both humans and systems. We developed an evolving dataset categorizing relevant measurement tools into five groups: cognitive ability, demographics &amp; personality, activity level, state of mind, and perceptions of the AI system. Each instance of the tool being used in the literature cataloged in the dataset is qualified in terms of how likely we would recommend using it in the domain of HAI for older adults with MCI based on contextual factors and internal reliability measures. This dataset will serve as a valuable resource for future research, aiding in the identification of promising areas and trends in AI systems for older adults with MCI as well as providing essential tools for future studies.</p> <h1>Methodology</h1> <p>This dataset was not derived through a typical literature review or survey process, but rather followed a more flexible research method. To collect resources for the dataset, we searched numerous databases to identify studies and review types of publications in journals and conferences between the dates of 2000 to 2022. For the papers that contained extensive reviews of literature or cited original tools, we would further look into the citations of those papers, taking us beyond our limited date range. The tools used were categorized into five groups to broadly distinguish their usage in a study, measuring:</p> <ol> <li>Cognitive ability</li> <li>Demographics, personality, and experiences</li> <li>Activity level</li> <li>State of mind</li> <li>Perceptions of the AI system</li> </ol> <p>Subsequently, we conducted an examination of their Cronbach&rsquo;s 𝛼 scores to assess internal reliability. We created tiers based on how likely we would be to recommend using each tool in the domain of human-AI (HAI) with older adults with MCI, as follows:</p> <ul> <li>Tier 1 included tools with Cronbach&rsquo;s 𝛼 &ge; 0.7 when used with older adults with MCI in experimental settings interacting with AI</li> <li>Tier 2 included tools with Cronbach&rsquo;s 𝛼 &ge; 0.7 when used with older adults, with or without MCI, in experimental settings with or without AI interaction</li> <li>Tier * included tools that satisfy the criteria for Tier 1, but, to the best of our knowledge, lack reported Cronbach&rsquo;s 𝛼 scores</li> <li>Tier 3 included all remaining tools that do not meet the criteria for Tier 1, 2, or *</li> </ul> <p>It should be emphasized that a tool may be found in one or more tiers because multiple studies used the same tool yet resulted in varying reliability scores, contexts, etc.</p> <h1>Contribute</h1> <p>Readers are encouraged to reach out to Adam Norton (adam[underscore]norton[at]uml.edu) to recommend additional tools and entries to the dataset.</p> <h1>Publication</h1> <p>This dataset is published as a short contribution to the Human-Robot Interaction (HRI) 2024 conference. The corresponding paper citation is below:</p> <p>Daisy M. Kiyemba, Jasmin Marwad, Elizabeth J. Carter, and Adam Norton. <strong>Evaluation Tools for Human-AI Interactions Involving Older Adults with Mild Cognitive Impairments</strong>. In Proceedings of the 2024 ACM/IEEE International Conference on Human-Robot Interaction (HRI &rsquo;24), March 11&ndash;14, 2024, Boulder, CO, USA. ACM, New York, NY, USA, 4 pages. <a href="https://doi.org/10.1145/3610977.3637474" target="_blank" rel="noopener">https://doi.org/10.1145/3610977.3637474</a></p> <h1>Acknowledgements</h1> <p>This work was supported by the National Science Foundation (IIS-2112633) as part of the AI-CARING Institute: <a href="https://ai-caring.org/" target="_blank" rel="noopener">https://ai-caring.org/</a></p>

opencc-by-4.0Jan 2024View details →
ClinicalTrials.gov40/100

Development and Evaluation of Virtual Reality Experiences for Cognitive Stimulation at the Sociosanitary Center El Carme

ClinicalTrials.gov study NCT06155721. IPD Sharing: NO. Countries: 1. Publications: 8.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov40/100

An Extension Study of HGT-HIT-045 Evaluating Long-Term Safety and Clinical Outcomes of Idursulfase-IT in Conjunction With Elaprase in Pediatric Participants With Hunter Syndrome and Cognitive Impairme

ClinicalTrials.gov study NCT01506141. IPD Sharing: YES. Countries: 3. Publications: 3.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

A Study to Evaluate the Effects of Basmisanil in Participants With Cognitive Impairment Associated With Schizophrenia (CIAS) Treated With Antipsychotics

ClinicalTrials.gov study NCT02953639. IPD Sharing: YES. Countries: 1. Publications: 0.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

Evaluation of a Diabetes-specific Cognitive Behavioural Treatment for Subthreshold Depression

ClinicalTrials.gov study NCT01009138. IPD Sharing: Not stated. Countries: 1. Publications: 6.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Evaluation of Cognitive State Using Neurosteer EEG System

ClinicalTrials.gov study NCT04386902. IPD Sharing: NO. Countries: 1. Publications: 7.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

Lisdexamfetamine Dimesylate (LDX) Pilot Cognition Study to Evaluate the Utility of a Standardized Battery of Tests in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)

ClinicalTrials.gov study NCT01010750. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Evaluating Two Types of Cognitive Training in Veterans With Schizophrenia

ClinicalTrials.gov study NCT01891721. IPD Sharing: NO. Countries: 1. Publications: 6.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

Evaluation of Cognitive State in Senior Subjects Using Neurosteer EEG System

ClinicalTrials.gov study NCT04683835. IPD Sharing: NO. Countries: 1. Publications: 6.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

Evaluation of DCTclock™ as a Cognitive Assessment Aid

ClinicalTrials.gov study NCT03238001. IPD Sharing: NO. Countries: 1. Publications: 4.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

Evaluation of a PMT Rehabilitation Nursing Plan for the Older Adults With MCI to Promote Cognitive Health

ClinicalTrials.gov study NCT07089654. IPD Sharing: YES. Countries: 1. Publications: 5.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

A Study to Evaluate the Tolerability of Botox and Topiramate or Botox and Placebo and Effect on Cognitive Efficiency

ClinicalTrials.gov study NCT01700387. IPD Sharing: Not stated. Countries: 1. Publications: 3.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Evaluation of the Efficacy of Varenicline on Cognition, Safety, Tolerability and Pharmacokinetics in Subjects With Mild-to-Moderate Alzheimer's Disease

ClinicalTrials.gov study NCT00744978. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Implementing and Evaluating an Internet-based Cognitive Behavior Therapy Intervention in School Settings

ClinicalTrials.gov study NCT04928001. IPD Sharing: NO. Countries: 1. Publications: 0.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

Evaluation of Flortaucipir PET Signal and Cognitive Change in Early Alzheimer's Disease

ClinicalTrials.gov study NCT03901105. IPD Sharing: NO. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

Biomarker Qualification for Risk of Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease (AD) and Safety and Efficacy Evaluation of Pioglitazone in Delaying Its Onset

ClinicalTrials.gov study NCT01931566. IPD Sharing: YES. Countries: 5. Publications: 2.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

Aging and Cognitive Health Evaluation in Elders (ACHIEVE)

ClinicalTrials.gov study NCT03243422. IPD Sharing: Not stated. Countries: 1. Publications: 7.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

A Study With an Open-label Extension Phase to Evaluate the Effect of Perampanel (E2007) on Cognition, Growth, Safety, Tolerability, and Pharmacokinetics in Adolescents

ClinicalTrials.gov study NCT01161524. IPD Sharing: Not stated. Countries: 11. Publications: 3.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Evaluating PCSK9 Binding antiBody Influence oN coGnitive HeAlth in High cardiovascUlar Risk Subjects

ClinicalTrials.gov study NCT02207634. IPD Sharing: Not stated. Countries: 30. Publications: 3.

restrictedIPD-UNDECIDEDFeb 2026View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record